Eikon Therapeutics appoints P&G veteran Fatima Francisco to board

Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc.

EIKN

0.00

  • Eikon appointed Ma. Fatima “Fama” D. Francisco as an independent director, effective June 15, 2026.
  • Francisco will join the board’s Compensation Committee.
  • She most recently led Procter & Gamble’s Baby, Feminine and Family Care unit as CEO.
  • She also serves on the boards of HP and Nestle, previously serving on Organon’s board.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eikon Therapeutics Inc. published the original content used to generate this news brief on June 08, 2026, and is solely responsible for the information contained therein.